Why the study?
Type 2 diabetes is a major health problem, and yoga is being explored as an alternative therapy for its management.
Does a comprehensive yogic breathing program reduce blood sugar, blood pressure, and pulse rate in patients with type 2 diabetes mellitus compared to non-diabetics?
Does a comprehensive yogic breathing program reduce blood sugar, blood pressure, and pulse rate in patients with type 2 diabetes mellitus compared to non-diabetics?
A 7-day comprehensive yogic breathing program including Sudarshan Kriya Yoga may significantly reduce blood sugar and pulse rate in patients with type 2 diabetes.
May support adjunctive yogic breathing in T2DM; observational data leaves effects open for RCT confirmation.
Introduction One of the major health problems in many countries including India is type 2 diabetes. Yoga is being explored as an alternative therapy for the management of diabetes. Methods Among the total of 137 participants who successfully completed the 'Living Well' workshop by the Art of Living, 84 with type 2 diabetes were assessed for change in random blood sugar levels, systolic and diastolic blood pressure levels (SBP/DBP), and pulse rate over seven days. In the Living Well workshop, the participants performed a comprehensive Yogic Breathing Program that included yogic movements and postures (Asana), relaxation practice, three-stage Pranayama, Sudarshan Kriya Yoga (SKY), breathing techniques, and discussion of stress relieving principles over those seven days. The parameters were recorded at the time of enrollment and after the completion of seven days of the workshop. Results There was a greater (p<0.05) percent reduction in the mean blood sugar level in diabetics as compared to non-diabetic individuals. However, the reduction in SBP and DBP were similar (p>0.05) in diabetics and non-diabetics. The percent reduction in the pulse rate however was greater (p<0.05) in diabetics than non-diabetics. Conclusion Comprehensive yogic breathing practices comprising SKY may be beneficial in patients with type 2 diabetes mellitus.
No takes yet. Share an insight, caveat, or question.
Verma et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: